Danaher Corporation, a global science and technology innovator, acquired the biopharma business of General Electric, an American multinational conglomerate, for $21bn. GE Biopharma is a leading provider of instruments, consumables, and software that support the research, discovery, process development and manufacturing workflows of biopharmaceutical drugs. The business is comprised of process chromatography hardware and consumables, cell culture media, single-use technologies, development instrumentation and consumables, and service.
Danaher's President and CEO, Thomas P. Joyce, Jr., said: "GE Biopharma is renowned for providing best-in-class bioprocessing technologies and solutions. This acquisition will bring a talented and passionate team as well as a highly innovative, industry-leading product suite to our Life Sciences portfolio, providing an excellent complement to our current biologics workflow solutions."
PJT Partners, JP Morgan, Goldman Sachs, Citigroup and Paul Weiss Rifkind Wharton & Garrison advised General Electric. Kirkland & Ellis advised Danaher.
Barrick Gold, the largest gold mining company in the world, made an $18bn offer for Newmont Mining, an American mining company. The proposal is for a merger in which each Newmont shareholder would receive 2.5694 Barrick shares per Newmont share. Barrick shareholders would own approximately 55.9% of the merged company and Newmont shareholders would own approximately 44.1%.
Barrick President and CEO Mark Bristow said the proposed merger is expected to unlock more than $7bn net present value of real synergies, a major portion of which is generated by combining the two companies’ highly complementary assets in Nevada, including Barrick’s significant mineral endowments and Newmont’s processing plants and infrastructure.
“The combination of Barrick and Newmont will create what is clearly the world’s best gold company, with the largest portfolio of Tier One gold assets and the highest level of free cash flow to drive future growth and support sustainable shareholder returns, run by a management team with an unparalleled record of delivering value,” he said.
CIBC, M. Klein, Cravath Swaine & Moore and Davies Ward Phillips & Vineberg advised Barrick Gold Corporation. BMO Capital Markets, Citigroup, Goldman Sachs, Goodmans, Wachtell Lipton Rosen & Katz and White & Case advised Newmont.
Roche, a global pioneer in pharmaceuticals and diagnostics, acquired Spark Therapeutics, a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, for $4.8bn. Under the terms of the agreement, Roche will acquire Spark Therapeutics at a price of $114.50 per share. The per share price represents a premium of 122% to Spark’s closing price on Feb. 22, 2019. The merger agreement has been unanimously approved by the boards of both Spark and Roche.
“As the only biotechnology company that has successfully commercialized a gene therapy for a genetic disease in the U.S., we have built unmatched competencies in the discovery, development and delivery of genetic medicines. However, the needs of patients and families living with genetic diseases are immediate and vast,” said Jeffrey D. Marrazzo, chief executive officer of Spark Therapeutics. “With its worldwide reach and extensive resources, Roche will help us accelerate the development of more gene therapies for more patients for more diseases and further expedite our vision of a world where no life is limited by genetic disease.”
Centerview Partners, Cowen and Goodwin Procter advised Spark Therapeutics. Citigroup and Davis Polk & Wardwell advised Roche.
Platinum Equity acquired Multi-Color Corporation, a leader in global label solutions supporting a number of the world’s most prominent brands including leading producers of home and personal care, wine and spirits, food and beverage, healthcare and specialty consumer products, for $50 in cash for each share of MCC, in a transaction valued at $2.5bn including the assumption of $1.5bn of debt. The purchase price represents a premium of approximately 32% over Multi-Color Corporation’s 30-day volume weighted average share price.
“We are pleased to reach this agreement with an affiliate of Platinum Equity,” said Nigel Vinecombe, Executive Chairman of Multi-Color Corporation. “This transaction is the culmination of our Board’s review of strategic alternatives to maximize value for our shareholders. As a result of this process, our Board, with the assistance of independent advisors, unanimously determined that this all-cash transaction will deliver immediate, significant and certain value to our shareholders and is in the best interest of our shareholders and our company. We believe this transaction represents a winning proposition for all of our stakeholders, including our employees.”
Goldman Sachs, William Blair, Sidley Austin and Keating Muething & Klekamp advised Multi-Color Corporation. Sullivan & Cromwell advised Goldman Sachs. Latham & Watkins advised Platinum Equity. Deutsche Bank and Bank of America Merrill Lynch provided debt financing and were advised by Cahill Gordon & Reindel.
Funds advised by Triton Partners and a wholly-owned subsidiary of the Abu Dhabi Investment Authority acquired IFCO, the leading global provider of reusable packaging solutions for fresh foods, from Brambles, an Australian company that specializes in the pooling of unit-load equipment and associated services, for $2.5bn.
Peder Prahl, Director of the General Partner for the Triton funds, said: "We look forward to actively supporting the management and employees of IFCO as a stable owner by investing in the growth and development of the company. Our strong industry expertise, gained through other investments and strengthened by senior industry experts, will contribute in taking the company to the next level.”
Rothschild & Co advised Brambles. Latham & Watkins advised Triton Partners.
Ipsen, a French pharmaceutical company headquartered in Paris, acquired Clementia Pharmaceuticals, a clinical-stage company innovating treatments for people with ultra-rare bone disorders and other diseases with high medical need, for $1.3bn. Under the terms of the agreement, Ipsen will pay $25 per share in cash upfront on completion of the transaction, for an initial aggregate consideration of $1.04bn, plus deferred payments on the achievement of a future regulatory milestone in the form of a contingent value right of $6 per share upon FDA acceptance of the NDA filing for palovarotene for the treatment of MO, representing an additional potential payment of $263m. The initial cash consideration represents a premium of 77% to Clementia’s 30-day volume-weighted average stock price.
David Meek, Chief Executive Officer of Ipsen, commented: “The acquisition of Clementia Pharmaceuticals accelerates the ongoing transformation of Ipsen as we are successfully executing on our external innovation strategy to identify and acquire innovative medicines to serve patients with unmet medical needs. Through this transaction, we will gain scientific expertise, exceptional talent, and a cornerstone ultra-rare disease drug candidate with rare pediatric disease and breakthrough therapy designations, potential U.S. approval in 2020 and additional indications to follow. We look forward to working closely with Clementia to successfully integrate two companies that share a similar patient-centric culture and the ambition to deliver new treatments to patients with unmet medical needs.”
Centerview Partners, Goodwin Procter and Davies Ward Phillips & Vineberg advised Ipsen. Morgan Stanley, Stikeman Elliott and Skadden Arps Slate Meagher & Flom advised Clementia Pharmaceuticals.
Private equity firm Quad-C Management agreed to sell its stake in Compassion-First, a family of well-known and respected specialty, emergency and general practice veterinary hospitals across the United States, to JAB Holdings, a privately held German conglomerate, based on a total enterprise valuation of $1.2bn.
“We are pleased to invest behind John and the management team as Compassion-First continues to deliver industry-leading organic growth and execute on its long-term strategy,” said David Bell, Partner at JAB. “The dedication to being the best place for veterinarians to work, the absolute commitment to putting patients first and the continual focus on innovation to improve the lives of both pets and their families are values very much in line with the those at JAB, and we look forward to partnering with John and his team to further Compassion-First’s success.”
Jefferies and Gibson Dunn & Crutcher advised Compassion-First. Skadden Arps Slate Meagher & Flom advised JAB Holdings.
Warburg Pincus acquired a majority stake in Kestra Financial, a leading independent investment advisory services provider, from Stone Point Capital. Funds managed by Stone Point Capital and Kestra Financial’s management team will maintain a minority stake in the company. Financial terms were not disclosed.
“We are thrilled to partner with James, the Kestra Financial team and Stone Point in the next chapter of Kestra Financial’s success. The company’s focus on providing best-in-class service and technology to its advisors and their clients positions the business for an exciting future,” said Arjun Thimmaya, Managing Director, Warburg Pincus. “We are committed to supporting Kestra Financial in their mission to build the leading wealth management platform to empower the success of their financial advisors,” added Jeff Stein, Managing Director, Warburg Pincus.
Goldman Sachs, Bank of America Merrill Lynch and Kramer Levin Naftalis & Frankel advised Kestra Financial. Kirkland & Ellis and Wachtell Lipton Rosen & Katz advised Warburg Pincus.
An investor group led by GTCR, a leading Chicago-based private equity firm, acquired AssuredPartners, a leading US insurance brokerage firm, from Apax Partners. The terms of the transaction were not disclosed.
Aaron Cohen, GTCR Managing Director, said: "We had an incredible experience working with the Assured team and have watched with admiration their continued success over the last three years. We want to congratulate the entire Assured organization on building a leading insurance broker with over $1bn of revenue in just eight years. AssuredPartners is a trusted advisor to its customers, offering unique capabilities to assist leading companies in all of their insurance and risk management needs. We are thrilled to be partners with Jim Henderson, Tom Riley and the team once again and look forward to the continued expansion of the AssuredPartners platform."
Bank of America Merrill Lynch, Kirkland & Ellis and Katten Muchin Rosenman advised AssuredPartners. Morgan Stanley and Latham & Watkins advised GTCR. Bank of America Merrill Lynch, Barclays, Harris Williams, Kirkland & Ellis and Simpson Thacher & Bartlett advised Apax.
Private equity firm Providence Equity Partners invested in TAIT, the market leader in designing, developing, and operating live event solutions for the entertainment industry. Financial terms were not disclosed.
Adam Davis, Chief Creative Officer at TAIT, said: “Providence is the ideal partner to help us accelerate our growth initiatives and strengthen our market position. We are proud to be a part of the Providence family and look forward to working with them to expand our offering for artists, entertainment companies and corporate brands that consistently turn to TAIT for spectacular live experiences.”
Evercore and Pepper Hamilton advised TAIT. Lazard and Weil Gotshal and Manges advised Providence Equity Partners.
Caesars Entertainment to offer Carl Icahn a role in selecting a new CEO. (FS)
Caesars Entertainment Corporation, an American gaming corporation based in Paradise, Nevada that owns and operates over 50 casinos and hotels, and seven golf courses under several brands, is in talks to offer Carl Icahn a role in selecting its new CEO as part of an agreement that would also give the billionaire investor board seats. The negotiations come after the investor disclosed a 9.8% stake in the company.
Icahn has proposed Anthony Rodio, the CEO of privately held casino gaming company Affinity Gaming, as the successor to Mark Frissora, who is due to step down as Caesars CEO later this year. Rodio was previously CEO of Tropicana Entertainment, another casino and resort operator that Icahn sold last year to Eldorado Resorts for $1.8bn.
Kraft Heinz looking to sell its Maxwell House coffee business. (FS)
Kraft Heinz, an American food company formed by the merger of Kraft Foods and Heinz and partially owned by Brazil’s buyout fund 3G Capital and Warren Buffett’s Berkshire Hathaway, is seeking a sale of its Maxwell House coffee business. The unit has about $400m in EBITDA and could attract a price of at least $3bn in a sale.
“We will explore asset sales according to this framework and will engage if this alternative is superior to us keeping the business and helps to improve the company’s growth and margin trajectory,” said Kraft Heinz spokesman Michael Mullen in an email to
Reuters on Sunday.
Warren Buffett, who entered the capital of the troubled food company in 2015, said on Monday that he was wrong about Kraft Heinz and that he overpaid for the company. Kraft Heinz’s share price drop of 27% on Friday cost Berkshire Hathaway to lose $4.3bn. Buffett also said he has “absolutely no intention” of adding to or subtracting from Berkshire’s stake.
Credit Suisse is advising Kraft Heinz on the sale.
Wind Point looking to sell Paragon Films for $500m. (FS)
Wind Point Partners is rumored to be looking to sell its portfolio company, Paragon Films, which manufactures and supplies stretch film products, for up to $500m. A final decision to pursue a sale hasn’t been made and Wind Point could decide to keep the company. The Chicago-based firm is currently working with an adviser to run an auction process for the company.
Colony Industrial sold its industrial portfolio to Nuveen Real Estate for $136m. (FS)
Colony Industrial, the industrial platform of Colony Capital, sold a light industrial portfolio to Nuveen Real Estate, a division of TIAA, the leading provider of financial services in the academic, research, medical, cultural and governmental fields, for $136m. The warehouse portfolio totals 2.3m square feet and is situated in four markets including eighteen buildings in Atlanta, five buildings in Dallas, five buildings in Houston and six buildings in Pennsylvania and New Jersey.
“We’ve owned and operated these assets for some time and the portfolio value had achieved Colony Industrial’s targets,” said Lew Friedland, Managing Director at Colony Capital and head of Colony Industrial. “We reevaluate the portfolio as opportunities arise, and this sale to Nuveen enables us to rebalance our property mix to align with Colony Industrial’s long-term strategic plans.”
CBRE National Partners advised Colony Industrial.
Genstar Capital raised $7bn for its ninth fund. (FS)
Genstar Capital, a leading private equity firm focused on investments in targeted segments of the financial services, software, industrial technology, and healthcare industries, announced the final closing of Genstar Capital Partners IX with $5.5bn in limited partner commitments. In addition, Genstar raised committed overage capacity of $1.1bn from select limited partners.
Commenting on the fundraising, Tony Salewski, Managing Director at Genstar, said: “We appreciate the tremendous support from our existing limited partners and the expansion of our base among leading global investors. The focus of this group allowed us to move quickly to close Fund IX within 15 weeks of the fund launch. We believe that our thesis-driven investing model of growing and building industry-leading businesses will continue to deliver superior performance for our investors.”
Evercore Partners served as Placement Agent for the fund, and Weil, Gotshal & Manges LLP provided legal advice.
SK Capital Partners raised $2.1bn for its fifth fund. (FS)
SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, announced the final close of SK Capital Partners Fund V with total committed capital of approximately $2.1bn. Fund V includes a separate overage fund that will enable the firm to provide greater speed and certainty to sellers when it pursues larger transactions.
“We are pleased by the tremendous demand for Fund V. Both the quality and diversity of our limited partners is indicative of their broad support for SK Capital’s disciplined strategy and strong team that incorporates both deep industry experience and diverse operating skill sets to deliver our targeted returns,” said Barry Siadat, Co-Founder and Managing Director of SK Capital Partners.
Kirkland & Ellis LLP served as legal advisor and UBS served as placement agent to SK Capital.
On-demand food service DoorDash secured $400m in Series F financing. (FS)
San Francisco-based DoorDash, an on-demand food service, raised $400m in Series F funding. Temasek and Dragoneer Investment Group led the round with participation from return backers Softbank Vision Fund, DST Global, Coatue Management, GIC, Sequoia Capital and Y Combinator. The investment values the company at $7.1bn.